A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding
- PMID: 11711301
- DOI: 10.1016/s0968-0896(01)00234-6
A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding
Abstract
A backbone bridged and disulfide bridged bicyclic somatostatin analogue, compound 1 (PTR-3205), was designed and synthesized by solid-phase methodology. The binding of compound 1 to the five different somatostatin receptors, expressed in CHO or COS-7 cells, indicate a high degree of selectivity towards hsstr2. The three-dimensional structure of this compound has been determined in DMSO-d(6) and in water by 1H NMR and by molecular dynamics simulations. Similar backbone conformations were observed in both solvents. We have established direct evidence that the backbone of this bicyclic somatostatin analogue assumes a 'folded' conformation in solution, where the lactam ring extends roughly in the plane of the beta-turn. The pharmacophoric region Phe-(D)-Trp-Lys-Thr of compound 1 is in accord with that of both the Veber compound L-363,301 (Merck) and sandostatin. We believe that the enhanced selectivity towards the hsst2 receptor, in comparison with other analogues, is due to its large hydrophobic region, composed of the lactam ring and the Phe side chains at positions 1 and 8.
Similar articles
-
Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units.J Med Chem. 2002 Apr 11;45(8):1665-71. doi: 10.1021/jm0100281. J Med Chem. 2002. PMID: 11931620
-
Highly potent and subtype selective ligands derived by N-methyl scan of a somatostatin antagonist.J Med Chem. 2001 Apr 12;44(8):1305-11. doi: 10.1021/jm0005048. J Med Chem. 2001. PMID: 11312929
-
Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues.J Med Chem. 1998 Jul 16;41(15):2686-92. doi: 10.1021/jm970392t. J Med Chem. 1998. PMID: 9667959
-
A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.J Pept Sci. 2001 Oct;7(10):521-8. doi: 10.1002/psc.348. J Pept Sci. 2001. PMID: 11695647
-
The beta-D-glucose scaffold as a beta-turn mimetic.Acc Chem Res. 2009 Oct 20;42(10):1511-20. doi: 10.1021/ar900020x. Acc Chem Res. 2009. PMID: 19624154 Free PMC article. Review.
Cited by
-
Peptide bicycles that inhibit the Grb2 SH2 domain.Chembiochem. 2012 Jul 9;13(10):1490-6. doi: 10.1002/cbic.201200175. Epub 2012 Jun 11. Chembiochem. 2012. PMID: 22689355 Free PMC article.
-
Detailed Insight into the Interaction of Bicyclic Somatostatin Analogue with Cu(II) Ions.Int J Mol Sci. 2020 Nov 20;21(22):8794. doi: 10.3390/ijms21228794. Int J Mol Sci. 2020. PMID: 33233719 Free PMC article.
-
Bicyclic Peptides as Next-Generation Therapeutics.Chemistry. 2017 Sep 18;23(52):12690-12703. doi: 10.1002/chem.201702117. Epub 2017 Jul 27. Chemistry. 2017. PMID: 28590540 Free PMC article. Review.
-
Novel sst2-selective somatostatin agonists. Three-dimensional consensus structure by NMR.J Med Chem. 2006 Jul 27;49(15):4487-96. doi: 10.1021/jm060363v. J Med Chem. 2006. PMID: 16854054 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources